Cite
HARVARD Citation
Bissonnette, R. et al. (n.d.). A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis. Journal of dermatological treatment. pp. 332-338. [Online].